|
TIC10
- 英文名称：TIC10
- 品牌：WYTSCI
- 产地：进口
- 型号：1MG
- 货号：WT-AY-B11105
- cas：1616632-77-9
- 价格： ￥1/mg
- 发布日期： 2025-04-10
- 更新日期： 2025-12-08
产品详请
| 产地 | 进口 |
| 品牌 | WYTSCI |
| 货号 | WT-AY-B11105 |
| 用途 | 科研检测 |
| 英文名称 | TIC10 |
| 包装规格 | 1MG |
| CAS编号 | 1616632-77-9 |
| 别名 | TIC10 |
| 纯度 | 98+% |
| 分子式 | |
| 是否进口 | 是 |
纯度:98% by TLC
分子式:C24H26N4O
分子量:386.49
溶剂:DMSO (25 mg/ml)
性状:Pale yellow solid
存储:-20°C
Activity (short version):Mitochondrial caseinolytic protease P activator / Anticancer agent
Function / Pharmacology:TIC10 (1616632-77-9) is novel anti-cancer compound that acts via early-stage integrated stress response activation leading to selective cancer cell death.1-3 TIC10 potently activates mitochondrial caseinolytic protease P (ClpP) causing eIF2?-independent induction of ATF4 and Akt/ERK/Foxo3a/DR5/TRAIL-dependent apoptosis.4 Currently in clinical trials.
分子式:C24H26N4O
分子量:386.49
溶剂:DMSO (25 mg/ml)
性状:Pale yellow solid
存储:-20°C
Activity (short version):Mitochondrial caseinolytic protease P activator / Anticancer agent
Function / Pharmacology:TIC10 (1616632-77-9) is novel anti-cancer compound that acts via early-stage integrated stress response activation leading to selective cancer cell death.1-3 TIC10 potently activates mitochondrial caseinolytic protease P (ClpP) causing eIF2?-independent induction of ATF4 and Akt/ERK/Foxo3a/DR5/TRAIL-dependent apoptosis.4 Currently in clinical trials.
